Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1991 1
1995 1
1996 2
1997 4
1998 2
1999 6
2000 4
2001 2
2002 3
2003 6
2004 9
2005 9
2006 11
2007 8
2008 13
2009 14
2010 22
2011 13
2012 13
2013 14
2014 24
2015 18
2016 15
2017 16
2018 19
2019 14
2020 17
2021 17
2022 27
2023 15
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Results by year

Filters applied: . Clear all
Page 1
Debamestrocel multimodal effects on biomarker pathways in amyotrophic lateral sclerosis are linked to clinical outcomes.
Lindborg SR, Goyal NA, Katz J, Burford M, Li J, Kaspi H, Abramov N, Boulanger B, Berry JD, Nicholson K, Mozaffar T, Miller R, Jenkins L, Baloh RH, Lewis R, Staff NP, Owegi MA, Dagher B, Blondheim-Shraga NR, Gothelf Y, Levy YS, Kern R, Aricha R, Windebank AJ, Bowser R, Brown RH Jr, Cudkowicz ME. Lindborg SR, et al. Among authors: cudkowicz me. Muscle Nerve. 2024 Jun;69(6):719-729. doi: 10.1002/mus.28093. Epub 2024 Apr 9. Muscle Nerve. 2024. PMID: 38593477 Clinical Trial.
Artificial intelligence in neurology: opportunities, challenges, and policy implications.
Voigtlaender S, Pawelczyk J, Geiger M, Vaios EJ, Karschnia P, Cudkowicz M, Dietrich J, Haraldsen IRJH, Feigin V, Owolabi M, White TL, Świeboda P, Farahany N, Natarajan V, Winter SF. Voigtlaender S, et al. Among authors: cudkowicz m. J Neurol. 2024 May;271(5):2258-2273. doi: 10.1007/s00415-024-12220-8. Epub 2024 Feb 17. J Neurol. 2024. PMID: 38367046 Review.
Identification of gene fusions associated with amyotrophic lateral sclerosis.
Raghav Y, Dilliott AA, Petrozziello T, Kim SE, Berry JD, Cudkowicz ME, Vakili K; NYGC ALS Consortium; Fraenkel E, Farhan SMK, Sadri-Vakili G. Raghav Y, et al. Among authors: cudkowicz me. Muscle Nerve. 2024 Apr;69(4):477-489. doi: 10.1002/mus.28043. Epub 2024 Feb 2. Muscle Nerve. 2024. PMID: 38305586
Effect of sodium phenylbutyrate and taurursodiol on plasma concentrations of neuroinflammatory biomarkers in amyotrophic lateral sclerosis: results from the CENTAUR trial.
Bowser R, An J, Mehta L, Chen J, Timmons J, Cudkowicz M, Paganoni S. Bowser R, et al. Among authors: cudkowicz m. J Neurol Neurosurg Psychiatry. 2023 Dec 2:jnnp-2023-332106. doi: 10.1136/jnnp-2023-332106. Online ahead of print. J Neurol Neurosurg Psychiatry. 2023. PMID: 38050066 Free article.
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Smith AG, Singleton JR, Aperghis A, Coffey CS, Creigh P, Cudkowicz M, Conwit R, Ecklund D, Fedler JK, Gudjonsdottir A, Hauer P, Herrmann DN, Kearney M, Kissel J, Klingner E, Quick A, Revere C, Stino A; NeuroNEXT NN108 TopCSPN Study Team. Smith AG, et al. Among authors: cudkowicz m. JAMA Neurol. 2023 Dec 1;80(12):1334-1343. doi: 10.1001/jamaneurol.2023.3711. JAMA Neurol. 2023. PMID: 37870862 Clinical Trial.
Analysis of sodium phenylbutyrate and taurursodiol survival effect in ALS using external controls.
Paganoni S, Quintana M, Sherman AV, Vestrucci M, Wu Y, Timmons J, Cudkowicz M; Pooled Resource Open-Access ALS Clinical Trials Consortium. Paganoni S, et al. Among authors: cudkowicz m. Ann Clin Transl Neurol. 2023 Dec;10(12):2297-2304. doi: 10.1002/acn3.51915. Epub 2023 Oct 9. Ann Clin Transl Neurol. 2023. PMID: 37807839 Free PMC article. Clinical Trial.
Effects of AFQ056 on language learning in fragile X syndrome.
Berry-Kravis E, Abbeduto L, Hagerman R, Coffey CS, Cudkowicz M, Erickson CA, McDuffie A, Hessl D, Ethridge L, Tassone F, Kaufmann WE, Friedmann K, Bullard L, Hoffmann A, Veenstra-VanderWeele J, Staley K, Klements D, Moshinsky M, Harkey B, Long J, Fedler J, Klingner E, Ecklund D, Costigan M, Huff T, Pearson B; NeuroNEXT FXLEARN Investigators. Berry-Kravis E, et al. Among authors: cudkowicz m. J Clin Invest. 2023 Aug 31;134(5):e171723. doi: 10.1172/JCI171723. J Clin Invest. 2023. PMID: 37651202 Free PMC article. Clinical Trial.
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
Shefner JM, Al-Chalabi A, Andrews JA, Chio A, De Carvalho M, Cockroft BM, Corcia P, Couratier P, Cudkowicz ME, Genge A, Hardiman O, Heiman-Patterson T, Henderson RD, Ingre C, Jackson CE, Johnston W, Lechtzin N, Ludolph A, Maragakis NJ, Miller TM, Mora Pardina JS, Petri S, Simmons Z, Van Den Berg LH, Zinman L, Kupfer S, Malik FI, Meng L, Simkins TJ, Wei J, Wolff AA, Rudnicki SA. Shefner JM, et al. Among authors: cudkowicz me. Amyotroph Lateral Scler Frontotemporal Degener. 2023 Aug;24(5-6):523-534. doi: 10.1080/21678421.2023.2216223. Epub 2023 May 30. Amyotroph Lateral Scler Frontotemporal Degener. 2023. PMID: 37254449 Clinical Trial.
310 results